Low-Dose Naltrexone (LDN) Mega Study
Contents
Low-Dose Naltrexone (LDN)
Low-Dose Naltrexone (LDN)

Related

A
Count
A
Treatments
A
Effects

Tags

Low-Dose Naltrexone
LDN

Treatment Effectiveness

User reported effectiveness ratings Low-Dose Naltrexone (LDN) for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Aging 47% 24% 6% 24% 0% 17
Allergic Rhinitis (Hay Fever) 20% 20% 20% 40% 0% 5
Arthritis 56% 25% 6% 13% 0% 16
Asthma 40% 20% 20% 20% 0% 5
Chronic Cerebrospinal Venous Insufficiency (CCSVI) 14% 14% 14% 43% 14% 7
Chronic Fatigue Syndrome 33% 29% 9% 27% 3% 79
Chronic Pain Syndrome 50% 50% 0% 0% 0% 4
Common Cold 67% 33% 0% 0% 0% 3
Endometriosis 25% 0% 0% 75% 0% 4
Fibromyalgia 54% 19% 4% 23% 0% 57
Hypothyroidism 17% 42% 0% 33% 8% 12
Irritable Bowel Syndrome 33% 17% 11% 33% 6% 18
Mitral Valve Prolapse 0% 20% 40% 40% 0% 5
Restless Legs Syndrome 33% 0% 0% 67% 0% 3

Below is the degree of change seen after Low-Dose Naltrexone (LDN) is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Low-Dose Naltrexone (LDN) Info

Property Value
Variable Name Low-Dose Naltrexone (LDN)
Aggregation Method SUM
Analysis Performed At 2020-03-26
Duration of Action 21 days
Filling Value 0
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 30 minutes
Unit Count
User Variables 0
Variable Category Treatments
Variable ID 94259